Bauche, S., Boerio, D., Davoine, C. S., Bernard, V., Stum, M., Bureau, C., Fardeau, M., Romero, N. B., Fontaine, B., Koenig, J., Hantai, D., Gueguen, A., Fournier, E., Eymard, B., Nicole, S. :
Peripheral nerve hyperexcitability with preterminal nerve and neuromuscular junction remodeling is a hallmark of Schwartz-Jampel syndrome
Neuromuscul Disord, 2013 ; 23 (12) : 998-1009
Publications (1181)
Bohm, J., Vasli, N., Malfatti, E., Le Gras, S., Feger, C., Jost, B., Monnier, N., Brocard, J., Karasoy, H., Gerard, M., Walter, M. C., Reilich, P., Biancalana, V., Kretz, C., Messaddeq, N., Marty, I., Lunardi, J., Romero, N. B., Laporte, J. :
An integrated diagnosis strategy for congenital myopathies PLoS ONE, 2013 ; 8 (6) : e67527
An integrated diagnosis strategy for congenital myopathies PLoS ONE, 2013 ; 8 (6) : e67527
Calhabeu, F., Hayashi, S., Morgan, J. E., Relaix, F., Zammit, P. S. :
Alveolar rhabdomyosarcoma-associated proteins PAX3/FOXO1A and PAX7/FOXO1A suppress the transcriptional activity of MyoD-target genes in muscle stem cells Oncogene, 2013 ; 32 (5) : 651-62
Alveolar rhabdomyosarcoma-associated proteins PAX3/FOXO1A and PAX7/FOXO1A suppress the transcriptional activity of MyoD-target genes in muscle stem cells Oncogene, 2013 ; 32 (5) : 651-62
Pilat, U., Dechat, T., Bertrand, A. T., Woisetschlager, N., Gotic, I., Spilka, R., Biadasiewicz, K., Bonne, G., Foisner, R. :
Muscle dystrophy-causing DeltaK32 lamin A/C mutant does not impair functions of nucleoplasmic LAP2alpha – lamin A/C complexes in mice J Cell Sci, 2013 ; 126 (Pt 8) : 1753-62
Muscle dystrophy-causing DeltaK32 lamin A/C mutant does not impair functions of nucleoplasmic LAP2alpha – lamin A/C complexes in mice J Cell Sci, 2013 ; 126 (Pt 8) : 1753-62
Calderon, J., Bonnet, D., Pinabiaux, C., Jambaque, I., Angeard, N. :
Use of early remedial services in children with transposition of the great arteries J Pediatr, 2013 ; 163 (4) : 1105-10
Use of early remedial services in children with transposition of the great arteries J Pediatr, 2013 ; 163 (4) : 1105-10
Haurigot, V., Marco, S., Ribera, A., Garcia, M., Ruzo, A., Villacampa, P., Ayuso, E., Anor, S., Andaluz, A., Pineda, M., Garcia-Fructuoso, G., Molas, M., Maggioni, L., Munoz, S., Motas, S., Ruberte, J., Mingozzi, F., Pumarola, M., Bosch, F. :
Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy J Clin Invest, 2013 ; (SP) :
Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy J Clin Invest, 2013 ; (SP) :
Mozzetta, C., Consalvi, S., Saccone, V., Tierney, M., Diamantini, A., Mitchell, K. J., Marazzi, G., Borsellino, G., Battistini, L., Sassoon, D., Sacco, A., Puri, P. L. :
Fibroadipogenic progenitors mediate the ability of HDAC inhibitors to promote regeneration in dystrophic muscles of young, but not old Mdx mice EMBO Mol Med, 2013 ; 5 (4) : 626-39
Fibroadipogenic progenitors mediate the ability of HDAC inhibitors to promote regeneration in dystrophic muscles of young, but not old Mdx mice EMBO Mol Med, 2013 ; 5 (4) : 626-39
Cousens, L. P., Najafian, N., Mingozzi, F., Elyaman, W., Mazer, B., Moise, L., Messitt, T. J., Su, Y., Sayegh, M., High, K., Khoury, S. J., Scott, D. W., De Groot, A. S. :
In vitro and in vivo studies of IgG-derived Treg epitopes (Tregitopes): a promising new tool for tolerance induction and treatment of autoimmunity J Clin Immunol, 2013 ; 33 Suppl 1 : S43-9
In vitro and in vivo studies of IgG-derived Treg epitopes (Tregitopes): a promising new tool for tolerance induction and treatment of autoimmunity J Clin Immunol, 2013 ; 33 Suppl 1 : S43-9
Berrih-Aknin, S., Souroujon, M. C. :
Myasthenia gravis: Special issue Autoimmun Rev, 2013 ; 12 (9) : 861-2
Myasthenia gravis: Special issue Autoimmun Rev, 2013 ; 12 (9) : 861-2
Gargiulo, M., Herson, A., Michon, C. C., Hogrel, J. Y., Doppler, V., Laloui, K., Herson, S., Payan, C., Eymard, B., Laforet, P. :
Attitudes and expectations of patients with neuromuscular diseases about their participation in a clinical trial Rev Neurol (Paris), 2013 ; 169 (8-9) : 670-676
Attitudes and expectations of patients with neuromuscular diseases about their participation in a clinical trial Rev Neurol (Paris), 2013 ; 169 (8-9) : 670-676
